Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Implementing “the safest medicines system in the world”

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, packaging, pharma

With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …
Feature

Long-term BMS exec Johanna Mercier joins Gilead as new Chief Commercial Officer

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead Sciences have said Bristol-Myers Squibb exec Johanna Mercier will be the firm’s new Chief Commercial Officer. In her new …
Appointment

Novartis Pharma head to become new Sanofi CEO

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, Sanofi, appointment, olivier brandicourt, pharma

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
News

Marie-France Tschudin, head of Novartis subsidiary AAA, takes over from Paul Hudson as Novartis Pharma CEO

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has said Marie-France Tschudin will take over from Paul Hudson as the head of Novartis Pharmaceuticals. The announcement comes …
Appointment

Top Ten most popular articles on Pharmafile.com this week!

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, EMA, Janssen, Orkambi, Pfizer

It was revealed this week that Pfizer suppressed findings that their anti-inflammatory Enbrel reduced the risk of Alzheimer’s by 64%. …
News

Healthcare communications: Time to think differently with patient centricity

June 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Spink, UK, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand …
News

Pfizer recruits new Group Head of Oncology R&D

June 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer has said Dr Jeff Settleman will join the firm as the company’s new Senior Vice President and Group Head …
Appointment

Battling cervical cancer in the developing world

June 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, Medecins sans frontieres; cancer, cervical cancer, malawi, pharma

The non-profit humanitarian organization Medecins Sans Frontieres, or Doctors Without Borders, is well known for its work fighting on the …
Feature

Eli Lilly’s Emgality approved in the US for episodic cluster headache

June 5, 2019 Research and Development, Sales and Marketing Eli Lilly, Emgality, episodic cluster headache, migraine, pharma

Eli Lilly’s Emgality (galcanezumab-gnlm) self-administered injection solution has secured approval in the US for the treatment of episodic cluster headache, …
News

NeoImmuneTech names experienced pharma exec Dr Samuel Zhang as company’s new Chief Business Officer

June 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Maryland-based biotech NeoImmuneTech has named Dr Samuel Zhang as the company’s new Chief Business Officer (CBO). Dr Zhang brings to …
Appointment

Former FDA Commissioner returns to venture capital firm

June 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma

Dr Scott Gottlieb, former Commissioner for the FDA, has returned to his venture capital background with the announcement that he …
Appointment

Amgen’s novel KRAS inhibitor monotherapy shows promise at Phase 1 in advanced solid tumours

June 4, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, KRAS

Amgen has unveiled the first clinical data for its investigational KRAS inhibitor AMG 510, the first such therapy to reach …
News

Working Life: Monika Pocinkova, Vice President, HR Speciality Care, Ipsen UK & Ireland

June 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, pharma

Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …
Feature

Janssen’s Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer

June 3, 2019 Research and Development, Sales and Marketing ASCO 2019, Cancer, Erleada, Janssen, prostate cancer

Janssen joined the showing at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago to present new …
News

Isatuximab improves on standard of care treatments for multiple myeloma

June 3, 2019 Sales and Marketing Cancer, Immunogen, Sanofi, isatuximab, multiple myeloma, pharma

Sanofi and ImmunoGen’s isatuximab combination therapy prolonged progression free survival by five months compared to standard of care treatments in …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026